Glipizide

Product NDC
65862-889
11-digit product format
658620889
Labeler code
65862
Product ID
65862-889_963bea5a-dda1-4ce0-9ee4-35e40eb82606
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Glipizide
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA206928
Marketing category
ANDA
Marketing start
2017-05-12
Marketing end
2020-07-31
Substance
GLIPIZIDE
Active strength
5 mg/1
Pharmacologic classes
Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ec4adfb0-aabc-95b9-ad07-5cb8f8533a09Product name220250625
b1de1ca9-d9db-4f4b-2103-09e2014d30d5Product name520180912
2dee091b-3b8c-d27a-b1ba-fcb0d32e776aProduct name120140508

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
314006glipiZIDE 5 MG 24HR Extended Release Oral TabletPSNc1cf510c-a4db-4292-8c20-4b15163e0f9d2
31400624 HR glipizide 5 MG Extended Release Oral TabletSCDc1cf510c-a4db-4292-8c20-4b15163e0f9d2
314006glipizide ER 5 MG 24 HR Extended Release Oral TabletSYc1cf510c-a4db-4292-8c20-4b15163e0f9d2
314006glipizide XL 5 MG 24 HR Extended Release Oral TabletSYc1cf510c-a4db-4292-8c20-4b15163e0f9d2